THC and the 5-HT2A Receptor: What’s Going On?
THC binding to 5-HT2A may activate signaling pathways that cause negative effects on cognition and memory.
Health - Page 11
Psychedelic-Assisted Therapy in the Post-Pandemic Era
In the wake of Covid-19, psychedelic-assisted therapy is gaining attention.
UC Berkeley Opens the Center for the Science of Psychedelics
"There's never been a better time to start a center like this."
MDMA, PTSD, and Potentially Overlooked Positive Outcomes
Measuring and increasing post-traumatic growth may lead to more rewarding interpersonal relationships, self-esteem, and a more optimistic outlook on life.
Ayahuasca Impacts the Big 5 Personality Traits
Research indicates that ayahuasca promotes sustained decreases in neuroticism and increases in agreeableness and openness.
Scientists Use Psychedelics to Discover an Anti-Inflammatory Pharmacophore
Integrating several tests into a SAR, scientists have identified the compound 2C-H as a structural basis of the anti-inflammatory response in rats.
Cybin’s Sublingual Psilocybin Strips Head to Clinical Trials for Dose-Finding
The first trial will determine the sublingual dose equivalent to 25 mg psilocybin administered orally.
MindMed and Liechti Lab to Conduct the First Clinical Trial Combining LSD and MDMA
Researchers will examine whether MDMA can offset some of the negative side effects of LSD in a therapeutic setting.
The Mechanisms of Change in Psychedelic Assisted Psychotherapy
A new study sheds light on cognitive behavioral change mechanisms underlying psychedelic assisted psychotherapy.
The Role of the Claustrum in the Psychedelic Experience
Brain scans show that psilocybin modulates claustrum connectivity in brain networks.